Email updates

Keep up to date with the latest news and content from BMC Psychiatry and BioMed Central.

Open Access Email this article to a friend

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

David H Adams*, Bruce J Kinon, Simin Baygani, Brian A Millen, Isabella Velona, Sara Kollack-Walker and David P Walling

BMC Psychiatry 2013, 13:143  doi:10.1186/1471-244X-13-143

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Psychiatry's emails?